|
WRN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.15280000000529E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.843500E-03 |
| Normal-vs-Stage2 |
9.789800E-02 |
| Normal-vs-Stage3 |
8.604300E-02 |
| Normal-vs-Stage4 |
4.074000E-01 |
| Stage1-vs-Stage2 |
9.185800E-01 |
| Stage1-vs-Stage3 |
4.366000E-01 |
| Stage1-vs-Stage4 |
9.773600E-01 |
| Stage2-vs-Stage3 |
5.272800E-01 |
| Stage2-vs-Stage4 |
9.186000E-01 |
| Stage3-vs-Stage4 |
6.303800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.848480E-04 |
| Normal-vs-AfricanAmerican |
6.908400E-02 |
| Normal-vs-Asian |
5.049000E-01 |
| Caucasian-vs-AfricanAmerican |
1.429800E-01 |
| Caucasian-vs-Asian |
5.674600E-01 |
| AfricanAmerican-vs-Asian |
7.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.881400E-03 |
| Normal-vs-Female |
9.77159999999699E-05 |
| Male-vs-Female |
7.219300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.991500E-02 |
| Normal-vs-Extreme_Weight |
7.383800E-02 |
| Normal-vs-Obese |
3.342500E-03 |
| Normal-vs-Extreme_Obese |
9.655600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.887800E-01 |
| Normal_Weight-vs-Obese |
9.549000E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.727960E-01 |
| Extreme_Weight-vs-Obese |
3.089200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.011400E-01 |
| Obese-vs-Extreme_Obese |
2.011200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.930120E-02 |
| Normal-vs-Age(41-60Yrs) |
1.6150899999956E-05 |
| Normal-vs-Age(61-80Yrs) |
7.824100E-02 |
| Normal-vs-Age(81-100Yrs) |
8.296000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.623800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.964200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.148300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.516500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.347500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.818380E-04 |
| Normal-VS-Type2 PRCC |
5.846200E-01 |
| Normal-VS-KIRP CIMP |
3.972500E-02 |
| Normal-VS-Unclassified PRCC |
1.399840E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.379600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.856390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.434200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.755600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.403610E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.880620E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.833000E-01 |
| Normal-vs-N1 |
3.179800E-02 |
| Normal-vs-N2 |
5.601000E-01 |
| N0-vs-N1 |
4.267900E-02 |
| N0-vs-N2 |
3.564000E-01 |
| N1-vs-N2 |
6.055200E-01 |
|
|
